nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—polycystic ovary syndrome	0.838	1	CbGaD
Hydroxyurea—Anaemia megaloblastic—Metformin—polycystic ovary syndrome	0.00643	0.176	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00504	0.066	CbGpPWpGaD
Hydroxyurea—RRM2—embryo—polycystic ovary syndrome	0.00416	0.0852	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00415	0.0543	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—CDC6—polycystic ovary syndrome	0.00404	0.0529	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00382	0.05	CbGpPWpGaD
Hydroxyurea—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—polycystic ovary syndrome	0.00366	0.0479	CbGpPWpGaD
Hydroxyurea—Emotional distress—Metformin—polycystic ovary syndrome	0.00357	0.0976	CcSEcCtD
Hydroxyurea—RRM1—Nucleotide Metabolism—RRM2—polycystic ovary syndrome	0.00351	0.0459	CbGpPWpGaD
Hydroxyurea—CYP2D6—urine—polycystic ovary syndrome	0.00317	0.065	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00315	0.0412	CbGpPWpGaD
Hydroxyurea—RRM2—endometrium—polycystic ovary syndrome	0.00304	0.0623	CbGeAlD
Hydroxyurea—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00288	0.0789	CcSEcCtD
Hydroxyurea—RRM1—adrenal cortex—polycystic ovary syndrome	0.00283	0.058	CbGeAlD
Hydroxyurea—RRM2—uterus—polycystic ovary syndrome	0.0028	0.0575	CbGeAlD
Hydroxyurea—RRM2—pituitary gland—polycystic ovary syndrome	0.00275	0.0564	CbGeAlD
Hydroxyurea—RRM2—adipose tissue—polycystic ovary syndrome	0.00274	0.0562	CbGeAlD
Hydroxyurea—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00258	0.0705	CcSEcCtD
Hydroxyurea—RRM1—endometrium—polycystic ovary syndrome	0.00253	0.0518	CbGeAlD
Hydroxyurea—RRM2—adrenal gland—polycystic ovary syndrome	0.00246	0.0504	CbGeAlD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—CDC6—polycystic ovary syndrome	0.00238	0.0311	CbGpPWpGaD
Hydroxyurea—RRM1—uterus—polycystic ovary syndrome	0.00233	0.0477	CbGeAlD
Hydroxyurea—RRM2—female gonad—polycystic ovary syndrome	0.00229	0.047	CbGeAlD
Hydroxyurea—RRM1—pituitary gland—polycystic ovary syndrome	0.00229	0.0469	CbGeAlD
Hydroxyurea—RRM2—vagina—polycystic ovary syndrome	0.00228	0.0467	CbGeAlD
Hydroxyurea—RRM1—adipose tissue—polycystic ovary syndrome	0.00228	0.0467	CbGeAlD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.00225	0.0295	CbGpPWpGaD
Hydroxyurea—RRM2—endocrine gland—polycystic ovary syndrome	0.00213	0.0437	CbGeAlD
Hydroxyurea—RRM1—adrenal gland—polycystic ovary syndrome	0.00204	0.0419	CbGeAlD
Hydroxyurea—RRM1—female gonad—polycystic ovary syndrome	0.0019	0.039	CbGeAlD
Hydroxyurea—RRM1—vagina—polycystic ovary syndrome	0.00189	0.0388	CbGeAlD
Hydroxyurea—RRM1—endocrine gland—polycystic ovary syndrome	0.00177	0.0363	CbGeAlD
Hydroxyurea—RRM1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.00163	0.0213	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00153	0.02	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00141	0.0185	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—CCNB1—polycystic ovary syndrome	0.00141	0.0184	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.00134	0.0175	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00126	0.0165	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.00123	0.0161	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.00119	0.0156	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00116	0.0152	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00114	0.0149	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.00113	0.0148	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00104	0.0136	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.00102	0.0133	CbGpPWpGaD
Hydroxyurea—Breast disorder—Metformin—polycystic ovary syndrome	0.000994	0.0272	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CCNE2—polycystic ovary syndrome	0.000972	0.0127	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000939	0.0123	CbGpPWpGaD
Hydroxyurea—Pancreatitis—Metformin—polycystic ovary syndrome	0.000932	0.0255	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDC6—polycystic ovary syndrome	0.000914	0.012	CbGpPWpGaD
Hydroxyurea—Neutropenia—Metformin—polycystic ovary syndrome	0.000889	0.0243	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000874	0.0114	CbGpPWpGaD
Hydroxyurea—Infestation NOS—Metformin—polycystic ovary syndrome	0.000848	0.0232	CcSEcCtD
Hydroxyurea—Infestation—Metformin—polycystic ovary syndrome	0.000848	0.0232	CcSEcCtD
Hydroxyurea—Drowsiness—Metformin—polycystic ovary syndrome	0.000848	0.0232	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000831	0.0227	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000819	0.0107	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000802	0.0219	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000787	0.0103	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.00077	0.0101	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000719	0.00941	CbGpPWpGaD
Hydroxyurea—Angiopathy—Metformin—polycystic ovary syndrome	0.000691	0.0189	CcSEcCtD
Hydroxyurea—Chills—Metformin—polycystic ovary syndrome	0.000683	0.0187	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000672	0.00879	CbGpPWpGaD
Hydroxyurea—Erythema—Metformin—polycystic ovary syndrome	0.000663	0.0181	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000648	0.00847	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000615	0.0168	CcSEcCtD
Hydroxyurea—Malaise—Metformin—polycystic ovary syndrome	0.000597	0.0163	CcSEcCtD
Hydroxyurea—CYP2D6—female gonad—polycystic ovary syndrome	0.000566	0.0116	CbGeAlD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00056	0.0153	CcSEcCtD
Hydroxyurea—Discomfort—Metformin—polycystic ovary syndrome	0.000557	0.0153	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CCNB1—polycystic ovary syndrome	0.000541	0.00708	CbGpPWpGaD
Hydroxyurea—Oedema—Metformin—polycystic ovary syndrome	0.000541	0.0148	CcSEcCtD
Hydroxyurea—Infection—Metformin—polycystic ovary syndrome	0.000537	0.0147	CcSEcCtD
Hydroxyurea—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00053	0.0145	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000529	0.0145	CcSEcCtD
Hydroxyurea—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000526	0.0108	CbGeAlD
Hydroxyurea—Skin disorder—Metformin—polycystic ovary syndrome	0.000525	0.0144	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000524	0.00686	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000523	0.00684	CbGpPWpGaD
Hydroxyurea—Anorexia—Metformin—polycystic ovary syndrome	0.000515	0.0141	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.000506	0.00662	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Metformin—polycystic ovary syndrome	0.000482	0.0132	CcSEcCtD
Hydroxyurea—Somnolence—Metformin—polycystic ovary syndrome	0.000481	0.0132	CcSEcCtD
Hydroxyurea—Dyspepsia—Metformin—polycystic ovary syndrome	0.000476	0.013	CcSEcCtD
Hydroxyurea—Decreased appetite—Metformin—polycystic ovary syndrome	0.00047	0.0129	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000468	0.00612	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000467	0.0128	CcSEcCtD
Hydroxyurea—Fatigue—Metformin—polycystic ovary syndrome	0.000466	0.0128	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000466	0.00609	CbGpPWpGaD
Hydroxyurea—Constipation—Metformin—polycystic ovary syndrome	0.000462	0.0127	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000456	0.00596	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000446	0.0122	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000441	0.00577	CbGpPWpGaD
Hydroxyurea—Asthenia—Metformin—polycystic ovary syndrome	0.000388	0.0106	CcSEcCtD
Hydroxyurea—Diarrhoea—Metformin—polycystic ovary syndrome	0.00037	0.0101	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000363	0.00475	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000362	0.00474	CbGpPWpGaD
Hydroxyurea—Dizziness—Metformin—polycystic ovary syndrome	0.000358	0.00978	CcSEcCtD
Hydroxyurea—Vomiting—Metformin—polycystic ovary syndrome	0.000344	0.00941	CcSEcCtD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000342	0.00448	CbGpPWpGaD
Hydroxyurea—Rash—Metformin—polycystic ovary syndrome	0.000341	0.00933	CcSEcCtD
Hydroxyurea—Dermatitis—Metformin—polycystic ovary syndrome	0.000341	0.00932	CcSEcCtD
Hydroxyurea—Headache—Metformin—polycystic ovary syndrome	0.000339	0.00927	CcSEcCtD
Hydroxyurea—Nausea—Metformin—polycystic ovary syndrome	0.000321	0.00879	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000309	0.00404	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000301	0.00393	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000287	0.00376	CbGpPWpGaD
Hydroxyurea—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000286	0.00375	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000283	0.0037	CbGpPWpGaD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000275	0.0036	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000269	0.00352	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000263	0.00343	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SUOX—polycystic ovary syndrome	0.000263	0.00343	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDC6—polycystic ovary syndrome	0.000253	0.0033	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000244	0.00319	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000236	0.00309	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000216	0.00283	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SUOX—polycystic ovary syndrome	0.000216	0.00283	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000215	0.00282	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000213	0.00278	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000208	0.00272	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TEAD2—polycystic ovary syndrome	0.000208	0.00271	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000208	0.00271	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000201	0.00263	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000201	0.00262	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000198	0.00259	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000194	0.00253	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000188	0.00246	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000188	0.00246	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000186	0.00244	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000186	0.00244	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000186	0.00243	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000184	0.00241	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000174	0.00228	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—LMNA—polycystic ovary syndrome	0.000173	0.00227	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000171	0.00224	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—TEAD2—polycystic ovary syndrome	0.000171	0.00224	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000167	0.00219	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000166	0.00217	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000165	0.00216	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000163	0.00213	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—STAR—polycystic ovary syndrome	0.000157	0.00206	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000151	0.00198	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000149	0.00196	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000148	0.00193	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000146	0.0019	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000143	0.00187	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000141	0.00184	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HMMR—polycystic ovary syndrome	0.00014	0.00183	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000136	0.00178	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000134	0.00175	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—STAR—polycystic ovary syndrome	0.00013	0.00169	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—LHB—polycystic ovary syndrome	0.000122	0.0016	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00012	0.00156	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000119	0.00156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000119	0.00156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000117	0.00154	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000115	0.00151	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HMMR—polycystic ovary syndrome	0.000115	0.00151	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.00144	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000106	0.00139	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000104	0.00137	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—RRM2—polycystic ovary syndrome	0.000103	0.00135	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—LHB—polycystic ovary syndrome	0.0001	0.00131	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—YAP1—polycystic ovary syndrome	9.92e-05	0.0013	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSD3B2—polycystic ovary syndrome	9.82e-05	0.00128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	9.75e-05	0.00128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.64e-05	0.00126	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.61e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NAMPT—polycystic ovary syndrome	9.53e-05	0.00125	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKR1C1—polycystic ovary syndrome	9.51e-05	0.00124	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP11A1—polycystic ovary syndrome	9.41e-05	0.00123	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1C3—polycystic ovary syndrome	8.89e-05	0.00116	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.87e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP17A1—polycystic ovary syndrome	8.75e-05	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SULT2A1—polycystic ovary syndrome	8.75e-05	0.00114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.63e-05	0.00113	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.52e-05	0.00111	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—YAP1—polycystic ovary syndrome	8.17e-05	0.00107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	8.04e-05	0.00105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	8.03e-05	0.00105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.92e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NAMPT—polycystic ovary syndrome	7.85e-05	0.00103	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP11A1—polycystic ovary syndrome	7.75e-05	0.00101	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TH—polycystic ovary syndrome	7.57e-05	0.00099	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC2A4—polycystic ovary syndrome	7.36e-05	0.000963	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKR1C3—polycystic ovary syndrome	7.32e-05	0.000957	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP17A1—polycystic ovary syndrome	7.21e-05	0.000942	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.19e-05	0.00094	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP19A1—polycystic ovary syndrome	6.92e-05	0.000906	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.35e-05	0.000831	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.27e-05	0.00082	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—TH—polycystic ovary syndrome	6.23e-05	0.000815	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GNAS—polycystic ovary syndrome	6.18e-05	0.000808	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC2A4—polycystic ovary syndrome	6.06e-05	0.000793	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOR1—polycystic ovary syndrome	5.89e-05	0.00077	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—polycystic ovary syndrome	5.7e-05	0.000746	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP1A1—polycystic ovary syndrome	5.58e-05	0.00073	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTHFR—polycystic ovary syndrome	5.2e-05	0.000681	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.12e-05	0.00067	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNAS—polycystic ovary syndrome	5.09e-05	0.000666	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.05e-05	0.000661	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR1—polycystic ovary syndrome	4.85e-05	0.000634	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1A1—polycystic ovary syndrome	4.6e-05	0.000601	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	4.5e-05	0.000589	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTHFR—polycystic ovary syndrome	4.28e-05	0.00056	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARG—polycystic ovary syndrome	4.22e-05	0.000552	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—POMC—polycystic ovary syndrome	4.16e-05	0.000544	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—INS—polycystic ovary syndrome	4.14e-05	0.000541	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	4.12e-05	0.000539	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	4.12e-05	0.000539	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	3.83e-05	0.000501	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	3.82e-05	0.000499	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARG—polycystic ovary syndrome	3.47e-05	0.000454	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—POMC—polycystic ovary syndrome	3.43e-05	0.000448	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—INS—polycystic ovary syndrome	3.41e-05	0.000446	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.26e-05	0.000426	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.26e-05	0.000426	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.73e-05	0.000357	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.59e-05	0.000338	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.47e-05	0.000323	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.2e-05	0.000288	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.1e-05	0.000274	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.91e-05	0.00025	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.87e-05	0.000245	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.81e-05	0.000237	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.67e-05	0.000218	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.61e-05	0.000211	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.56e-05	0.000204	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.5e-05	0.000196	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.48e-05	0.000193	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.39e-05	0.000182	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.37e-05	0.00018	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.19e-05	0.000155	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.16e-05	0.000151	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.09e-05	0.000142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	9.7e-06	0.000127	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.24e-06	0.000121	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.76e-06	0.000115	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.16e-06	0.000107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.62e-06	8.66e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.53e-06	8.54e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.49e-06	8.49e-05	CbGpPWpGaD
